Millennium Management’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Buy
+1,549,850
New +$3.6M ﹤0.01% 3484
2023
Q1
Sell
-3,535
Closed -$31K 6578
2022
Q4
$31K Sell
3,535
-1,323
-27% -$44.8K ﹤0.01% 5924
2022
Q3
$414K Sell
4,858
-4,373
-47% -$602K ﹤0.01% 5121
2022
Q2
$1.22M Buy
+9,231
New +$1.39M ﹤0.01% 4199
2022
Q1
Sell
-192
Closed -$53K 7146
2021
Q4
$53K Buy
+192
New +$73.2K ﹤0.01% 6462
2021
Q3
Sell
-38
Closed -$29K 6989
2021
Q2
$29K Sell
38
-329
-90% -$240K ﹤0.01% 6415
2021
Q1
$282K Buy
367
+105
+40% +$91.5K ﹤0.01% 5253
2020
Q4
$137K Sell
262
-263
-50% -$214K ﹤0.01% 4963
2020
Q3
$533 Buy
525
+279
+113% +$404K ﹤0.01% 3542
2020
Q2
$273K Buy
246
+72
+41% +$47.1K ﹤0.01% 3710
2020
Q1
$92K Buy
+174
New +$67K ﹤0.01% 3564
2016
Q3
Sell
-2
Closed -$7K 3405
2016
Q2
$7K Sell
2
-9
-82% -$29.4K ﹤0.01% 3120
2016
Q1
$31K Buy
+11
New +$31.5K ﹤0.01% 3175
2014
Q4
Sell
-3
Closed -$9K 4074
2014
Q3
$9K Buy
+3
New +$7.32K ﹤0.01% 3639

Other funds holding IBIO

Millennium Management's IBIO Position: Q1 2026 in Review

Millennium Management opened a new position in iBio (IBIO) in Q1 2026: 1,549,850 shares worth $2.94M. The stake represents ﹤0.01% of the portfolio and ranks #3484 among its holdings. This is a return to the name: Millennium Management previously reported a position in IBIO as recently as Q4 2022.

Millennium Management first reported a position in IBIO in Q3 2014 and has held it in 14 quarters since. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Millennium Management held 1,549,850 shares of iBio worth $2.94M as of Q1 2026.
  • iBio was a new Millennium Management position in Q1 2026.
  • iBio made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3484 holding.
  • Millennium Management first reported a position in iBio in Q3 2014 and has held it in 14 quarters since.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.